Aging, Author Interviews, Cost of Health Care, JAMA, University of Michigan / 10.02.2020
Many Adults Approaching Retirement Avoid Medical Care Because of Cost Concerns
MedicalResearch.com Interview with:
[caption id="attachment_53089" align="alignleft" width="200"]
Dr. Tipirneni[/caption]
Renuka Tipirneni, MD, MSc, FACP
Assistant Professor
Holder of the Grace H. Elta MD Department of Internal Medicine
Early Career Endowment Award 2019-2024
University of Michigan Department of Internal Medicine
Divisions of General Medicine and Hospital Medicine
and Institute for Healthcare Policy & Innovation
Ann Arbor, MI 48109
MedicalResearch.com: What is the background for this study?
Response: While U.S. adults age 50-64 previously had more limited options for health insurance before Medicare at age 65, the Affordable Care Act expanded the number of options, including Marketplace plans (e.g., through HealthCare.gov) and Medicaid. This expanded set of options may complicate decisions about health insurance near retirement. In addition, several policy challenges to the Affordable Care Act may add uncertainty to the decision-making process.
Dr. Tipirneni[/caption]
Renuka Tipirneni, MD, MSc, FACP
Assistant Professor
Holder of the Grace H. Elta MD Department of Internal Medicine
Early Career Endowment Award 2019-2024
University of Michigan Department of Internal Medicine
Divisions of General Medicine and Hospital Medicine
and Institute for Healthcare Policy & Innovation
Ann Arbor, MI 48109
MedicalResearch.com: What is the background for this study?
Response: While U.S. adults age 50-64 previously had more limited options for health insurance before Medicare at age 65, the Affordable Care Act expanded the number of options, including Marketplace plans (e.g., through HealthCare.gov) and Medicaid. This expanded set of options may complicate decisions about health insurance near retirement. In addition, several policy challenges to the Affordable Care Act may add uncertainty to the decision-making process.

Deborah M Eaton
Doctorate Student / Research Assistant
Temple University
MedicalResearch.com: What is the background for this study?
Response: Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for approximately 50% of cases of HF and to date clinical trials with HFpEF patients have failed to produce positive outcomes. Part of this is likely due to the lack of HFpEF animal models for preclinical testing. Our lab addressed this gap in knowledge by developing an animal model that mimics critical features of the human HFpEF phenotype. We performed an in-depth cardiopulmonary characterization highlighting that the model has characteristics of human disease. We then tested the effects of a pan-HDAC inhibitor, vorinostat/SAHA, in collaboration with Dr. Timothy McKinsey, who is an expert in HDAC inhibitors and recently published work1 that laid the foundation for this study.


Dr. Hongying (Daisy) Dai[/caption]
Hongying (Daisy) Dai, PhD
Associate Professor
Department of Biostatistics | College of Public Health
University of Nebraska Medical Center
Omaha, NE
MedicalResearch.com: What is the background for this study?
Response: E-cigarette use increased dramatically from 11.7% to 27.5% for high school students and from 3.3% to 10.5% for middle school students during the periods of 2017 - 2019. In September 2018, the Food and Drug Administration (FDA) warned that youth e-cigarette use is reaching an epidemic proportion.
Exposure to secondhand aerosol (SHA) from e-cigarettes is not harmless as e-cigarettes aerosol contains nicotine and potentially harmful substances, including carbonyl compounds, TSNAs, heavy metals, and glycols. This study analyzed the 2015-2018 National Youth Tobacco Survey (NYTS) and the main findings are:
Prof. Woloshin[/caption]
Steven Woloshin, MD, MS
Professor of Medicine and Community and Family Medicine
Professor, The Dartmouth Institute for Health Policy and Clinical Practice
MedicalResearch.com: What is the background for this study?
Response: Industry spends more on detailing visits and free samples than any other form of prescription drug marketing. There is good evidence that these activities can lead to more use of expensive new drugs over equally effective cheaper options. Given these concerns there have been efforts by some hospitalls and practices to restrict these forms of marketing.
We asked physicians in group practices delivering primary care about how often pharmaceutical reps visit their practice and whether they have a free sample closet.